almagate has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, JS; Lü, YH; Wang, QZ; Yang, HY; Zhu, Y | 1 |
Becker, RC; Nimjee, SM; Sullenger, BA; White, RR | 1 |
Cavalli, M; Gatto, B | 1 |
2 review(s) available for almagate and Neoplasms
Article | Year |
---|---|
[Recent progress of the aptamer-based antiviral drugs].
Topics: Antiviral Agents; Aptamers, Nucleotide; Genome, Viral; Hepacivirus; HIV; HIV Reverse Transcriptase; Humans; Macular Degeneration; Neoplasms; Oligodeoxyribonucleotides; RNA, Small Interfering; SELEX Aptamer Technique; Viral Envelope Proteins; Virus Replication | 2013 |
Aptamers as Therapeutics.
Topics: Animals; Aptamers, Nucleotide; Humans; Neoplasms; Randomized Controlled Trials as Topic; SELEX Aptamer Technique; Vision Disorders | 2017 |
1 other study(ies) available for almagate and Neoplasms
Article | Year |
---|---|
From proteins to nucleic acid-based drugs: the role of biotech in anti-VEGF therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Protein Engineering; Ranibizumab; RNA, Small Interfering; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2006 |